Kumar, S., Goldschmidt, H., & Hillengaß, J. (2016). International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. The lancet. Oncology, 17(8), . https://doi.org/10.1016/S1470-2045(16)30206-6
Chicago-Zitierstil (17. Ausg.)Kumar, Shaji, Hartmut Goldschmidt, und Jens Hillengaß. "International Myeloma Working Group Consensus Criteria for Response and Minimal Residual Disease Assessment in Multiple Myeloma." The Lancet. Oncology 17, no. 8 (2016). https://doi.org/10.1016/S1470-2045(16)30206-6.
MLA-Zitierstil (9. Ausg.)Kumar, Shaji, et al. "International Myeloma Working Group Consensus Criteria for Response and Minimal Residual Disease Assessment in Multiple Myeloma." The Lancet. Oncology, vol. 17, no. 8, 2016, https://doi.org/10.1016/S1470-2045(16)30206-6.